Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Clin Oral Implants Res. 2013 Feb 27;25(7):803–812. doi: 10.1111/clr.12139

Figure 1.

Figure 1

A. At the screening visit (-1 month), participant eligibility was assessed. The baseline visit (0) for the enrolled subjects was scheduled within 1 month from the screening visit and involved the described study procedures. The follow-up visit (12 months) was scheduled 12 months after the baseline within a window of 6 weeks. Similar procedures to the baseline appointment were performed with the addition of blood sampling. B. Thirty-two subjects were enrolled in the study, 18 in the control group and 14 in the test group. All participants completed the investigation with the exception of one subject in the diabetes group.